The level of inflammation in rheumatoid arthritis is determined early and remains stable over the longterm course of the illness

Journal of Rheumatology

Volumn 28, Issue 8, 2001, Pages 1817-1824

  Wolfe, F ^a   Pincus, T ^a  

^a NATIONAL DATA BANK FOR RHEUMATIC DISEASES   (United States)

Author keywords

Erythrocyte sedimentation rate; Inflammation; Longitudinal; Outcome; Rheumatoid arthritis

Indexed keywords

ADULT; ARTICLE; CHRONIC INFLAMMATION; DISEASE ACTIVITY; DISEASE ASSOCIATION; DISEASE COURSE; DISEASE DURATION; ERYTHROCYTE SEDIMENTATION RATE; FEMALE; FOLLOW UP; HUMAN; MALE; MODEL; PRIORITY JOURNAL; RHEUMATOID ARTHRITIS; UNITED STATES;

ADULT; ARTHRITIS, RHEUMATOID; BLOOD SEDIMENTATION; DISEASE PROGRESSION; FEMALE; HUMANS; LONGITUDINAL STUDIES; MALE; MIDDLE AGED; REGRESSION ANALYSIS;

EID: 0034902710     PISSN: 0315162X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (49)

1. The clinical and research significance of the erythrocyte sedimentation rate
2. Prediction of erosiveness and rate of development of new erosions in early rheumatoid arthritis
3. Rheumatoid arthritis: C-reactive protein and erythrocyte sedimentation rate during initial treatment
4. The assessment of disease activity in rheumatoid arthritis using a multivariate analysis
5. Correlation of clinical parameters of disease activity in rheumatoid arthritis with serum concentration of C-reactive protein and erythrocyte sedimentation rate
6. A comparison between clinical and laboratory tests in rheumatoid arthritis
7. Rheumatoid arthritis: Treatment which controls the C-reactive protein and erythrocyte sedimentation rate reduces radiological progression
8. Articular indices of joint inflammation in rheumatoid arthritis. Correlation with the acute-phase response
9. Rheumatoid arthritis: Rheumatoid factors, immune complexes, and C-reactive protein are raised shortly after the onset of symptoms
10. Comparison and evaluation of a disease activity index for use in patients with rheumatoid arthritis
11. Prognostic factors for radiographic damage and physical disability in early rheumatoid arthritis. A prospective follow-up study of 147 patients
12. The relationship between serial measures of disease activity and outcome in rheumatoid arthritis
13. A simple index to assess disease activity in rheumatoid arthritis
14. Validity of single variables and indices to measure disease activity in rheumatoid arthritis
15. The acute-phase response in relation to radiographic progression in early rheumatoid arthritis: A prospective study during the first three years of the disease
16. Effects of gold, dapsone, and prednisone on serum C-reactive protein and haptoglobin and the erythrocyte sedimentation rate in rheumatoid arthritis
17. Comparative usefulness of C-reactive protein and erythrocyte sedimentation rate in patients with rheumatoid arthritis
18. Sensitivity to change of the Health Assessment Questionnaire and other clinical and health status measures in rheumatoid arthritis: Results of short term clinical trials and observational studies versus long term observational studies
19. Prognostic markers of activity and damage in rheumatoid arthritis: Why clinical trials and inception cohort studies indicate more favorable outcomes than studies of patients with established disease
20. Measures of activity and damage in rheumatoid arthritis: Depiction of changes and prediction of mortality over five years
21. Early effective suppression of inflammation in rheumatoid arthritis reduces radiographic progression
22. "No evidence of disease" in rheumatoid arthritis using methotrexate in combination with other drugs: A contemporary goal for rheumatology care?
23. Rheumatoid arthritis: Treat now, not later!
24. Management of patients with newly diagnosed rheumatoid arthritis
25. The comparative efficacy and toxicity of second-line drugs in rheumatoid arthritis. Results of two metaanalyses
26. A meta-analysis of the effects of nonsteroidal anti-inflammatory drugs on blood pressure
27. Second-line antirheumatic therapies
28. Analysis of treatment termination with gold and antimalarial compounds in rheumatoid arthritis
29. Practical results of treatment with disease-modifying antirheumatoid drugs
30. Termination of slow acting antirheumatic therapy in rheumatoid arthritis: A 14-year prospective evaluation of 1017 consecutive starts
31. Longterm drug therapy for rheumatoid arthritis in seven rheumatology private practices. 1. Nonsteroidal antiinflammatory drugs
32. Order out of chaos - The primary mission of the pyramid
33. Treatment of rheumatoid arthritis
34. Severe functional declines, work disability, and increased mortality in seventy-five rheumatoid arthritis patients studied over nine years
35. Progression of radiographical changes in rheumatoid arthritis
36. Radiographic outcome of recent-onset rheumatoid arthritis: A 19-year study of radiographic progression
37. The progression of erosion and joint space narrowing scores in rheumatoid arthritis during the first 25 years of disease
38. The longterm outcomes of rheumatoid arthritis: Work disability: A prospective 18 year study of 823 patients
39. Work disability in rheumatoid arthritis: Effects of disease, social, and work factors
40. The long-term outcomes of rheumatoid arthritis: A 23-year prospective, longitudinal study of total joint replacement and its predictors in 1,600 patients with rheumatoid arthritis
41. Taking mortality in rheumatoid arthritis seriously - Predictive markers, socioeconomic status and comorbidity
42. The mortality of rheumatoid arthritis
43. Development of radiographic damage during the first 5-6 yr of rheumatoid arthritis. A prospective follow-up study of a Swedish cohort
44. Clinical improvement and radiological deterioration in rheumatoid arthritis: Evidence that the pathogenesis of synovial inflammation and articular erosion may differ
45. The American College of Rheumatology preliminary core set of disease activity measures for rheumatoid arthritis clinical trials. The committee on outcome measures in rheumatoid arthritis clinical trials
46. Disease activity in rheumatoid arthritis - Preliminary report of the consensus study group of the European Workshop for rheumatology research
47. The clinical and research significance of the erythrocyte sedimentation rate
48. Regression using fractional polynomials of continuous covariates: Parsimonious parametric modeling